WP8 of the U-PGx project provides an Ethical, Legal and Societal Implications (ELSI) expertise and education on ethical and legal aspects regarding Pharmacogenomics (PGx). Continue reading →

In the PREPARE study participants are genotyped pre-emptively, but what to do for all other patients? Can you initiate therapy without pre-emptive testing or is genotyping necessary for specific drugs? Continue reading →

The 6th U-PGx Personalized Medicine Day will be organized in Athens, Greece on December 13th, 2019. Continue reading →

As per October 1st 2018, the PREPARE study sites have crossed-over to the opposite arm! Since then, more than 1,000 patients have been enrolled in the PREPARE study. When adding this number up to the number of patients enrolled before cross-over we come to a total of 4,772 patients. Continue reading →

During the Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT) in Washington D.C. on March 13th 2019, the Pharmacogenomics Research Network (PGRN) presented a Trainee Abstract Award to U-PGx’s Cathelijne van der Wouden. Continue reading →

The 6th U-PGx Personalized Medicine Day will be held in Stuttgart, Germany on the 25th of February 2019.

Continue reading →

The 5th U-PGx Personalized Medicine Day was successfully co-organized by the Golden Helix Foundation and the University of Liverpool, both partners of the Ubiquitous Pharmacogenomics (U-PGx) project, funded by the European Commission (H2020-668353). Continue reading →

The 4th U-PGx Personalized Medicine Day will be organized in Stockholm, Sweden at 18th of June 2018. Continue reading →

The U-PGx Summer School will be organized August 20th to 23th in Bonn, Germany. Continue reading →